Aromatherapy for Chemotherapy-induced Symptoms

Stopped early · Early Phase 1

Conditions studied: Chemotherapy Symptoms

In brief

The rationale behind the proposed study is to determine the initial effectiveness of aromatherapy in relief of commonly reported symptoms in cancer patients undergoing chemotherapy.

Key facts

Study ID

NCT02670941

Run by

University of Rochester

People needed

31

Starts

2016-01-01

Expected to finish

2018-09-12

Last updated by the study team

2019-01-24

Who can join

Age: 21 and older, up to 89. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Non-pregnant adults between the ages of 21 to 89 years of age with diagnosis of cancer and be scheduled to receive at least three more cycles of chemotherapy.
• Subjects must have had at least one chemotherapy cycle in their current prescribed course and have at least three additional chemotherapy cycles planned.
• Day 1 of each chemotherapy cycle must be separated from Day 1 of the next chemotherapy cycles by at least 12 days.
• All chemotherapy regimens are eligible.
• Any number of chemotherapy administrations per week during a chemotherapy treatment cycle is allowed.
• Subjects agree to discontinue any current aromatherapy usage and only use the study aromatherapy for symptom management during the course of the study. NOTE: Patients can continue to use scented soaps, lotions, shampoos, body sprays, perfume/cologne, candles, or air fresheners that they regularly use.
• Subjects must be able to read and understand English, as well as provide informed consent in order to participate in this study.

You may not qualify if…

• Subjects < 21 years old or > 89 years old are not eligible for participation in this study at the University of Rochester.
• Pregnant females are ineligible for the study because pregnancy is a contraindication for chemotherapy and exposure to essentials oils.
• Subjects who are chemotherapy-naïve are ineligible.
• Subjects with more than four weeks between chemotherapy treatment cycles are not eligible.
• Concurrent radiation therapy or interferon treatment is not allowed.
• Subjects that have used or are currently using aromatherapy inhalation for symptom management are not eligible.
• Subjects with any known allergy to ginger, lavender, orange, citrus of any kind, jojoba, or essential oils.

Where it is running

• University of Rochester Medical Center, Wilmot Canter Center — Rochester, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.